Joe DePinto, Head of InspiroGene by McKesson, is a guest author on this article.

Insights by Joe

Critical Success Factors for Commercializing Cell & Gene Therapies (6): Elevated Patient Experience and Engagement – Meeting Patients Where They Are

Critical Success Factors for Commercializing Cell & Gene Therapies (5): Supplemental Evidence Generation – Why the Data Story Doesn’t End at Approval

Need help? Contact us today.

We're excited to learn about your strategic business objectives and brainstorm how to help you achieve them.

Want to Join Our Team?

Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.